Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 22 | 2022 | 1626 | 2.180 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2021 | 1113 | 2.030 |
Why?
|
| Cognitive Dysfunction | 13 | 2022 | 998 | 1.650 |
Why?
|
| Gait | 6 | 2021 | 391 | 1.350 |
Why?
|
| Hippocampus | 6 | 2020 | 247 | 1.280 |
Why?
|
| Exercise | 6 | 2021 | 447 | 1.080 |
Why?
|
| Cognition | 10 | 2022 | 1263 | 1.060 |
Why?
|
| Aged, 80 and over | 30 | 2022 | 4503 | 0.990 |
Why?
|
| Alzheimer Disease | 15 | 2022 | 1981 | 0.970 |
Why?
|
| Aging | 8 | 2021 | 1520 | 0.910 |
Why?
|
| Postural Balance | 3 | 2021 | 115 | 0.900 |
Why?
|
| Postmortem Changes | 2 | 2016 | 31 | 0.860 |
Why?
|
| Neuropathology | 3 | 2021 | 82 | 0.850 |
Why?
|
| Independent Living | 5 | 2021 | 305 | 0.850 |
Why?
|
| Male | 37 | 2022 | 13545 | 0.730 |
Why?
|
| Wearable Electronic Devices | 5 | 2021 | 39 | 0.720 |
Why?
|
| Female | 37 | 2022 | 13844 | 0.710 |
Why?
|
| White Matter | 5 | 2018 | 143 | 0.700 |
Why?
|
| Humans | 49 | 2022 | 25178 | 0.650 |
Why?
|
| Aged | 27 | 2022 | 8397 | 0.620 |
Why?
|
| Autopsy | 9 | 2021 | 336 | 0.610 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2021 | 69 | 0.600 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2018 | 53 | 0.590 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2018 | 114 | 0.550 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 645 | 0.520 |
Why?
|
| Motor Activity | 1 | 2018 | 305 | 0.500 |
Why?
|
| Atrophy | 3 | 2021 | 88 | 0.470 |
Why?
|
| Thalamus | 3 | 2021 | 21 | 0.470 |
Why?
|
| Knee Joint | 1 | 2019 | 681 | 0.440 |
Why?
|
| Parkinsonian Disorders | 3 | 2020 | 212 | 0.410 |
Why?
|
| Accelerometry | 4 | 2021 | 87 | 0.390 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 70 | 0.390 |
Why?
|
| Walking | 4 | 2022 | 249 | 0.380 |
Why?
|
| Neuroimaging | 3 | 2021 | 133 | 0.370 |
Why?
|
| Walking Speed | 2 | 2021 | 40 | 0.350 |
Why?
|
| Gray Matter | 3 | 2021 | 55 | 0.340 |
Why?
|
| Longitudinal Studies | 7 | 2021 | 1299 | 0.340 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 201 | 0.340 |
Why?
|
| Formaldehyde | 1 | 2009 | 10 | 0.330 |
Why?
|
| RNA, Messenger | 2 | 2022 | 240 | 0.330 |
Why?
|
| Cohort Studies | 9 | 2020 | 1756 | 0.310 |
Why?
|
| Temporal Lobe | 2 | 2020 | 84 | 0.300 |
Why?
|
| Brain Mapping | 3 | 2017 | 164 | 0.300 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 202 | 0.290 |
Why?
|
| Parkinson Disease | 4 | 2021 | 818 | 0.270 |
Why?
|
| Dementia | 2 | 2022 | 516 | 0.270 |
Why?
|
| Organ Size | 3 | 2015 | 97 | 0.250 |
Why?
|
| Nerve Net | 2 | 2021 | 46 | 0.220 |
Why?
|
| Sclerosis | 3 | 2019 | 66 | 0.220 |
Why?
|
| DNA Methylation | 3 | 2019 | 117 | 0.210 |
Why?
|
| Transcriptome | 2 | 2022 | 79 | 0.210 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 87 | 0.210 |
Why?
|
| Neuropsychological Tests | 3 | 2022 | 1189 | 0.210 |
Why?
|
| Proteome | 1 | 2022 | 41 | 0.190 |
Why?
|
| Tremor | 2 | 2021 | 116 | 0.190 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 8 | 0.190 |
Why?
|
| Proteomics | 1 | 2022 | 87 | 0.190 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 11 | 0.190 |
Why?
|
| Motor Skills | 1 | 2021 | 51 | 0.190 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 130 | 0.190 |
Why?
|
| Neuropeptides | 2 | 2019 | 29 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2019 | 109 | 0.180 |
Why?
|
| Frailty | 1 | 2021 | 34 | 0.180 |
Why?
|
| Hand Strength | 1 | 2021 | 56 | 0.180 |
Why?
|
| Gene Expression | 2 | 2019 | 176 | 0.180 |
Why?
|
| Sarcopenia | 1 | 2021 | 31 | 0.180 |
Why?
|
| Cognitive Aging | 1 | 2021 | 73 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 109 | 0.170 |
Why?
|
| Cognition Disorders | 3 | 2017 | 939 | 0.170 |
Why?
|
| Brain Ischemia | 1 | 2020 | 59 | 0.170 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 6 | 0.170 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 8 | 0.170 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 18 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 106 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 161 | 0.170 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 11 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 26 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 82 | 0.160 |
Why?
|
| Disabled Persons | 1 | 2021 | 123 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 139 | 0.160 |
Why?
|
| Memory | 3 | 2017 | 293 | 0.160 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2018 | 12 | 0.160 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 35 | 0.160 |
Why?
|
| Bone Resorption | 1 | 2019 | 74 | 0.160 |
Why?
|
| Muscle Strength | 1 | 2019 | 126 | 0.150 |
Why?
|
| Nerve Fibers | 1 | 2018 | 12 | 0.150 |
Why?
|
| Young Adult | 6 | 2021 | 1749 | 0.150 |
Why?
|
| Adult | 10 | 2021 | 7087 | 0.140 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 22 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2019 | 276 | 0.140 |
Why?
|
| Circle of Willis | 1 | 2017 | 5 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 31 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2017 | 73 | 0.140 |
Why?
|
| Ultraviolet Therapy | 1 | 2017 | 1 | 0.140 |
Why?
|
| Linear Models | 2 | 2016 | 231 | 0.140 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 25 | 0.140 |
Why?
|
| Epithalamus | 1 | 2016 | 3 | 0.140 |
Why?
|
| Afferent Pathways | 1 | 2016 | 5 | 0.140 |
Why?
|
| Plasmacytoma | 1 | 2016 | 13 | 0.140 |
Why?
|
| Sphenoid Sinus | 1 | 2016 | 15 | 0.140 |
Why?
|
| Femur | 1 | 2020 | 352 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 77 | 0.140 |
Why?
|
| Neurons | 1 | 2019 | 287 | 0.140 |
Why?
|
| Skin Diseases | 1 | 2017 | 22 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 143 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 150 | 0.130 |
Why?
|
| Neocortex | 1 | 2016 | 31 | 0.130 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 62 | 0.130 |
Why?
|
| Algorithms | 2 | 2019 | 351 | 0.130 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 315 | 0.120 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 217 | 0.120 |
Why?
|
| Middle Aged | 8 | 2021 | 8135 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 59 | 0.120 |
Why?
|
| Joint Instability | 1 | 2019 | 344 | 0.120 |
Why?
|
| Locomotion | 1 | 2014 | 21 | 0.110 |
Why?
|
| Shoulder Joint | 1 | 2019 | 563 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2010 | 39 | 0.090 |
Why?
|
| Memory, Episodic | 1 | 2011 | 114 | 0.090 |
Why?
|
| Mortality | 2 | 2021 | 81 | 0.090 |
Why?
|
| Fixatives | 1 | 2009 | 6 | 0.080 |
Why?
|
| Sex Factors | 2 | 2021 | 429 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 2166 | 0.080 |
Why?
|
| Chicago | 2 | 2021 | 782 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 191 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 250 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 186 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 685 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 642 | 0.060 |
Why?
|
| Adolescent | 3 | 2017 | 1998 | 0.060 |
Why?
|
| Photosensitivity Disorders | 1 | 2003 | 1 | 0.060 |
Why?
|
| Sunlight | 1 | 2003 | 2 | 0.060 |
Why?
|
| Urticaria | 1 | 2003 | 3 | 0.060 |
Why?
|
| Depression | 2 | 2017 | 395 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 24 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 36 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 67 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 112 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2021 | 29 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 726 | 0.050 |
Why?
|
| Frail Elderly | 1 | 2021 | 49 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 1621 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 199 | 0.040 |
Why?
|
| Movement | 1 | 2020 | 109 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Nestin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 14 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 8 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2019 | 9 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2020 | 92 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 19 | 0.040 |
Why?
|
| SNARE Proteins | 1 | 2019 | 13 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3105 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 13 | 0.040 |
Why?
|
| Software | 1 | 2019 | 65 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 183 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 54 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2019 | 467 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 104 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 11 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 44 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 832 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 41 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 720 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 664 | 0.040 |
Why?
|
| Child | 2 | 2017 | 1232 | 0.040 |
Why?
|
| Shoulder Injuries | 1 | 2019 | 130 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2018 | 250 | 0.040 |
Why?
|
| Netrin Receptors | 1 | 2017 | 5 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 649 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 41 | 0.040 |
Why?
|
| RNA | 1 | 2017 | 32 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 902 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2017 | 9 | 0.040 |
Why?
|
| Habenula | 1 | 2016 | 3 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 62 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 67 | 0.030 |
Why?
|
| Phototherapy | 1 | 2017 | 38 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 498 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 209 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 126 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 280 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 338 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 292 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 58 | 0.030 |
Why?
|
| Actigraphy | 1 | 2016 | 85 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1589 | 0.030 |
Why?
|
| United States | 1 | 2021 | 1899 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 145 | 0.030 |
Why?
|
| Muscle Rigidity | 1 | 2014 | 22 | 0.030 |
Why?
|
| Hypokinesia | 1 | 2014 | 23 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 272 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2013 | 43 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 169 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 254 | 0.030 |
Why?
|
| Cadaver | 1 | 2013 | 323 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 467 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 572 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2003 | 588 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1327 | 0.010 |
Why?
|